Transgenomic Inc - TBIO - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Transgenomic Inc - SIC # 3826

Ticker	Exchange	SIC #	Website	Latest Ticker
TBIO	Over the counter	3826	http://www.transgenomic.com	0.47 +0.005
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Transgenomic Inc TRANSGENOMIC INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders - May 22nd, 2013 7:25 am TRANSGENOMIC INC Financials - May 17th, 2013 11:04 am Transgenomic Announces Global Availability of CRC RAScan™ Mutation Detection Test for Use in Patients with Metastatic Colorectal Cancer to Help Identify Appropriate Treatment - May 16th, 2013 5:00 am Q1 Revenue In-Line. Amgen Deal Is Encouraging - May 10th, 2013 7:10 am TBIO: Q1 Revenue In-Line. Amgen Deal Is Encouraging - May 10th, 2013 5:45 am TRANSGENOMIC INC Files SEC form 10-Q, Quarterly Report - May 9th, 2013 2:53 am Transgenomic's CEO Discusses Q1 2013 Results - Earnings Call Transcript - May 8th, 2013 7:55 pm Transgenomic Reports First Quarter 2013 Financial Results - May 8th, 2013 2:00 pm TRANSGENOMIC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits - May 8th, 2013 7:19 am Reminder: Transgenomic to Hold First Quarter Financial Results Conference Call Today - May 8th, 2013 7:11 am Q1 2013 Transgenomic, Inc. Earnings Release - Time Not Supplied - May 8th, 2013 5:07 am Transgenomic Signs Collaboration Agreement with Amgen for Development of CE-IVD CRC RAScan™ Mutation Detection Tests for Patients with Metastatic Colorectal Cancer - May 6th, 2013 5:00 am Transgenomic to Hold First Quarter Financial Results Conference Call on May 8, 2013 - May 1st, 2013 7:53 am TRANSGENOMIC INC Files SEC form 8-K, Change in Directors or Principal Officers - Apr 29th, 2013 6:59 am Transgenomic Receives 2013 Governor’s Bioscience Award at Bio Nebraska Annual Meeting - Apr 19th, 2013 8:27 am TBIO: Look For Resurgence In 2013 - Mar 15th, 2013 2:23 pm TBIO: Look For Resurgence In 2013 - Mar 15th, 2013 1:00 pm New Star Analyst Rankings for TRANSGENOMIC INC - Mar 14th, 2013 6:03 pm TRANSGENOMIC INC Files SEC form 10-K, Annual Report - Mar 14th, 2013 2:45 pm TRANSGENOMIC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits - Mar 13th, 2013 2:51 pm View All Current Headlines >>